Quest Total Other Income Expense Net vs Selling And Marketing Expenses Analysis

DGX Stock

USD 134.26 1.16 0.86%

Quest Diagnostics financial indicator trend analysis is much more than just breaking down Quest Diagnostics prevalent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Quest Diagnostics is a good investment. Please check the relationship between Quest Diagnostics Total Other Income Expense Net and its Selling And Marketing Expenses accounts. Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Quest Diagnostics Incorporated. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in price.

Total Other Income Expense Net vs Selling And Marketing Expenses

Total Other Income Expense Net vs Selling And Marketing Expenses Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Quest Diagnostics Total Other Income Expense Net account and Selling And Marketing Expenses. At this time, the significance of the direction appears to have weak contrarian relationship.

The correlation between Quest Diagnostics' Total Other Income Expense Net and Selling And Marketing Expenses is -0.17. Overlapping area represents the amount of variation of Total Other Income Expense Net that can explain the historical movement of Selling And Marketing Expenses in the same time period over historical financial statements of Quest Diagnostics Incorporated, assuming nothing else is changed. The correlation between historical values of Quest Diagnostics' Total Other Income Expense Net and Selling And Marketing Expenses is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Total Other Income Expense Net of Quest Diagnostics Incorporated are associated (or correlated) with its Selling And Marketing Expenses. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Selling And Marketing Expenses has no effect on the direction of Total Other Income Expense Net i.e., Quest Diagnostics' Total Other Income Expense Net and Selling And Marketing Expenses go up and down completely randomly.

Correlation Coefficient

-0.17

Relationship Direction	Negative
Relationship Strength	Insignificant

View All Relationships

Total Other Income Expense Net

Selling And Marketing Expenses

Most indicators from Quest Diagnostics' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Quest Diagnostics current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Quest Diagnostics Incorporated. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in price.

At this time, Quest Diagnostics' Discontinued Operations is fairly stable compared to the past year. Tax Provision is likely to rise to about 266.4 M in 2024, whereas Selling General Administrative is likely to drop slightly above 1.5 B in 2024.

	2021	2022	2023	2024 (projected)
Gross Profit	4.2B	3.4B	3.1B	2.7B
Total Revenue	10.8B	9.9B	9.3B	6.9B

Gross Profit Total Revenue

Quest Diagnostics fundamental ratios Correlations

	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Property Plant And Equipment Net	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Non Currrent Assets Other	Cash And Short Term Investments	Net Receivables	Common Stock Total Equity	Common Stock Shares Outstanding	Non Current Liabilities Total	Inventory	Other Current Assets	Other Stockholder Equity	Total Liab	Property Plant And Equipment Gross	Total Current Assets	Short Term Debt	Common Stock	Intangible Assets
Total Assets		0.97	0.65	0.87	0.99	0.71	0.91	0.86	0.19	0.61	0.99	0.11	0.61	0.94	0.81	-0.09	0.99	0.84	0.25	-0.79	0.99	0.38	0.87	0.29	0.82	0.92
Short Long Term Debt Total	0.97		0.6	0.91	0.93	0.65	0.95	0.81	0.19	0.59	0.97	0.14	0.59	0.85	0.83	-0.03	0.97	0.75	0.26	-0.77	0.99	0.36	0.81	0.48	0.84	0.9
Other Current Liab	0.65	0.6		0.65	0.65	0.87	0.55	0.82	0.73	0.56	0.63	-0.27	0.56	0.68	0.47	-0.46	0.59	0.7	0.19	-0.73	0.63	0.83	0.62	0.22	0.4	0.66
Total Current Liabilities	0.87	0.91	0.65		0.82	0.66	0.84	0.73	0.22	0.64	0.85	0.11	0.64	0.82	0.71	-0.04	0.83	0.74	0.28	-0.66	0.9	0.38	0.82	0.66	0.7	0.87
Total Stockholder Equity	0.99	0.93	0.65	0.82		0.73	0.86	0.88	0.19	0.61	0.98	0.06	0.61	0.95	0.77	-0.13	0.97	0.86	0.21	-0.8	0.96	0.37	0.87	0.2	0.78	0.91
Property Plant And Equipment Net	0.71	0.65	0.87	0.66	0.73		0.52	0.84	0.65	0.76	0.67	-0.17	0.76	0.76	0.39	-0.58	0.66	0.82	-0.03	-0.71	0.69	0.81	0.77	0.18	0.34	0.63
Net Debt	0.91	0.95	0.55	0.84	0.86	0.52		0.75	0.14	0.33	0.94	0.19	0.33	0.75	0.9	0.07	0.93	0.62	0.39	-0.75	0.94	0.3	0.62	0.45	0.91	0.89
Retained Earnings	0.86	0.81	0.82	0.73	0.88	0.84	0.75		0.48	0.63	0.86	-0.03	0.63	0.82	0.73	-0.2	0.83	0.71	0.17	-0.95	0.83	0.64	0.73	0.22	0.69	0.85
Accounts Payable	0.19	0.19	0.73	0.22	0.19	0.65	0.14	0.48		0.38	0.17	-0.06	0.38	0.2	0.17	-0.51	0.18	0.31	0.17	-0.4	0.2	0.97	0.25	0.08	0.09	0.17
Cash	0.61	0.59	0.56	0.64	0.61	0.76	0.33	0.63	0.38		0.52	-0.04	1.0	0.68	0.26	-0.3	0.55	0.68	-0.18	-0.5	0.59	0.52	0.88	0.32	0.24	0.45
Non Current Assets Total	0.99	0.97	0.63	0.85	0.98	0.67	0.94	0.86	0.17	0.52		0.12	0.52	0.91	0.85	-0.06	0.99	0.79	0.27	-0.81	0.98	0.35	0.8	0.29	0.86	0.93
Non Currrent Assets Other	0.11	0.14	-0.27	0.11	0.06	-0.17	0.19	-0.03	-0.06	-0.04	0.12		-0.04	0.06	0.47	0.63	0.18	-0.01	0.56	0.13	0.17	-0.09	0.07	-0.02	0.49	0.01
Cash And Short Term Investments	0.61	0.59	0.56	0.64	0.61	0.76	0.33	0.63	0.38	1.0	0.52	-0.04		0.68	0.26	-0.3	0.55	0.68	-0.18	-0.5	0.59	0.52	0.88	0.32	0.24	0.45
Net Receivables	0.94	0.85	0.68	0.82	0.95	0.76	0.75	0.82	0.2	0.68	0.91	0.06	0.68		0.68	-0.14	0.9	0.93	0.18	-0.68	0.91	0.38	0.93	0.15	0.68	0.85
Common Stock Total Equity	0.81	0.83	0.47	0.71	0.77	0.39	0.9	0.73	0.17	0.26	0.85	0.47	0.26	0.68		0.37	0.85	0.48	0.57	-0.69	0.84	0.27	0.54	0.29	0.99	0.8
Common Stock Shares Outstanding	-0.09	-0.03	-0.46	-0.04	-0.13	-0.58	0.07	-0.2	-0.51	-0.3	-0.06	0.63	-0.3	-0.14	0.37		-0.03	-0.4	0.39	0.18	-0.04	-0.57	-0.21	0.08	0.39	-0.02
Non Current Liabilities Total	0.99	0.97	0.59	0.83	0.97	0.66	0.93	0.83	0.18	0.55	0.99	0.18	0.55	0.9	0.85	-0.03		0.8	0.27	-0.77	0.99	0.35	0.82	0.26	0.86	0.88
Inventory	0.84	0.75	0.7	0.74	0.86	0.82	0.62	0.71	0.31	0.68	0.79	-0.01	0.68	0.93	0.48	-0.4	0.8		0.1	-0.57	0.81	0.48	0.9	0.08	0.48	0.7
Other Current Assets	0.25	0.26	0.19	0.28	0.21	-0.03	0.39	0.17	0.17	-0.18	0.27	0.56	-0.18	0.18	0.57	0.39	0.27	0.1		-0.1	0.29	0.11	0.1	0.04	0.57	0.22
Other Stockholder Equity	-0.79	-0.77	-0.73	-0.66	-0.8	-0.71	-0.75	-0.95	-0.4	-0.5	-0.81	0.13	-0.5	-0.68	-0.69	0.18	-0.77	-0.57	-0.1		-0.77	-0.54	-0.59	-0.27	-0.66	-0.81
Total Liab	0.99	0.99	0.63	0.9	0.96	0.69	0.94	0.83	0.2	0.59	0.98	0.17	0.59	0.91	0.84	-0.04	0.99	0.81	0.29	-0.77		0.37	0.85	0.38	0.85	0.91
Property Plant And Equipment Gross	0.38	0.36	0.83	0.38	0.37	0.81	0.3	0.64	0.97	0.52	0.35	-0.09	0.52	0.38	0.27	-0.57	0.35	0.48	0.11	-0.54	0.37		0.42	0.15	0.19	0.34
Total Current Assets	0.87	0.81	0.62	0.82	0.87	0.77	0.62	0.73	0.25	0.88	0.8	0.07	0.88	0.93	0.54	-0.21	0.82	0.9	0.1	-0.59	0.85	0.42		0.26	0.54	0.7
Short Term Debt	0.29	0.48	0.22	0.66	0.2	0.18	0.45	0.22	0.08	0.32	0.29	-0.02	0.32	0.15	0.29	0.08	0.26	0.08	0.04	-0.27	0.38	0.15	0.26		0.27	0.41
Common Stock	0.82	0.84	0.4	0.7	0.78	0.34	0.91	0.69	0.09	0.24	0.86	0.49	0.24	0.68	0.99	0.39	0.86	0.48	0.57	-0.66	0.85	0.19	0.54	0.27		0.79
Intangible Assets	0.92	0.9	0.66	0.87	0.91	0.63	0.89	0.85	0.17	0.45	0.93	0.01	0.45	0.85	0.8	-0.02	0.88	0.7	0.22	-0.81	0.91	0.34	0.7	0.41	0.79

Click cells to compare fundamentals

Quest Diagnostics Account Relationship Matchups

Quest Diagnostics fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	12.8B	14.0B	13.6B	12.8B	14.0B	8.5B
Short Long Term Debt Total	5.3B	4.7B	4.7B	4.6B	5.4B	3.1B
Other Current Liab	778M	1.2B	1.2B	1.1B	1.5B	1.6B
Total Current Liabilities	2.0B	1.8B	1.8B	1.6B	1.8B	1.2B
Total Stockholder Equity	5.6B	6.8B	6.4B	5.9B	6.3B	3.9B
Property Plant And Equipment Net	2.0B	2.2B	2.3B	2.4B	2.4B	2.5B
Net Debt	4.1B	3.5B	3.8B	4.3B	4.7B	2.7B
Retained Earnings	8.2B	9.3B	7.6B	8.3B	8.8B	9.3B
Accounts Payable	263M	446M	357M	324M	1.4B	1.4B
Cash	1.2B	1.2B	872M	315M	686M	720.3M
Non Current Assets Total	10.4B	11.0B	10.9B	10.9B	11.7B	6.9B
Non Currrent Assets Other	160M	176M	163M	144M	198M	177.5M
Cash And Short Term Investments	1.2B	1.2B	872M	315M	686M	720.3M
Net Receivables	1.1B	1.5B	1.4B	1.2B	1.2B	892.3M
Liabilities And Stockholders Equity	12.8B	14.0B	13.6B	12.8B	14.0B	8.5B
Non Current Liabilities Total	5.1B	5.4B	5.3B	5.3B	5.8B	3.3B
Inventory	123M	223M	208M	192M	190M	104.0M
Other Current Assets	112M	157M	223M	196M	286M	227.8M
Other Stockholder Equity	(2.5B)	(2.5B)	(1.2B)	(2.4B)	(2.5B)	(2.4B)
Total Liab	7.1B	7.1B	7.0B	6.8B	7.6B	4.6B
Property Plant And Equipment Gross	2.0B	2.2B	2.3B	2.4B	5.8B	6.1B
Total Current Assets	2.5B	3.1B	2.7B	1.9B	2.4B	1.6B
Accumulated Other Comprehensive Income	(59M)	(39M)	(21M)	(14M)	14M	14.7M
Short Term Debt	949M	143M	153M	155M	456M	241.5M
Intangible Assets	1.2B	1.1B	1.2B	1.1B	1.2B	968.0M
Other Liab	683M	847M	792M	812M	933.8M	472.6M
Other Assets	64M	1.3B	163M	144M	165.6M	196.9M
Long Term Debt	4.0B	4.0B	4.0B	4.0B	4.4B	3.0B
Property Plant Equipment	1.5B	1.6B	2.3B	2.4B	2.7B	2.8B
Good Will	6.6B	6.9B	7.1B	7.2B	7.7B	5.7B
Treasury Stock	(5.2B)	(5.4B)	(3.5B)	(4.7B)	(4.2B)	(4.4B)
Net Tangible Assets	(1.6B)	(700M)	(1.8B)	(1.9B)	(2.1B)	(2.2B)
Noncontrolling Interest In Consolidated Entity	46M	50M	39M	37M	42.6M	34.3M
Retained Earnings Total Equity	8.2B	9.3B	7.6B	8.3B	9.5B	6.6B

Pair Trading with Quest Diagnostics

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Quest Diagnostics position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Quest Diagnostics will appreciate offsetting losses from the drop in the long position's value.

Moving against Quest Stock

0.68	EGRX	Eagle Pharmaceuticals	Pair Corr
0.62	ETON	Eton Pharmaceuticals Upward Rally	Pair Corr
0.62	EVOK	Evoke Pharma	Pair Corr
0.61	EXAI	Exscientia ADR Financial Report 22nd of May 2024	Pair Corr
0.51	TFX	Teleflex Incorporated Earnings Call This Week	Pair Corr

The ability to find closely correlated positions to Quest Diagnostics could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Quest Diagnostics when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Quest Diagnostics - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Quest Diagnostics Incorporated to buy it.

The correlation of Quest Diagnostics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Quest Diagnostics moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Quest Diagnostics moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.

Correlation analysis and pair trading evaluation for Quest Diagnostics can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.

Pair Correlation Correlation Matching

When determining whether Quest Diagnostics offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Quest Diagnostics' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Quest Diagnostics Incorporated Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Quest Diagnostics Incorporated Stock:

How To Invest In Quest

Details

Is Quest Stock a good investment?

Details

What is Quest Diagnostics' Net Worth?

Details

Largest Health Care Providers & Services Companies

View

Largest Health Care Equipment & Services Companies

View

Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Quest Diagnostics Incorporated. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in price.

Note that the Quest Diagnostics information on this page should be used as a complementary analysis to other Quest Diagnostics' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Financial Widgets module to easily integrated Macroaxis content with over 30 different plug-and-play financial widgets.

Complementary Tools for Quest Stock analysis

When running Quest Diagnostics' price analysis, check to measure Quest Diagnostics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Quest Diagnostics is operating at the current time. Most of Quest Diagnostics' value examination focuses on studying past and present price action to predict the probability of Quest Diagnostics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Quest Diagnostics' price. Additionally, you may evaluate how the addition of Quest Diagnostics to your portfolios can decrease your overall portfolio volatility.

	Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk
	Content Syndication Quickly integrate customizable finance content to your own investment portal
	My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
	Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
	Commodity Channel Use Commodity Channel Index to analyze current equity momentum
	Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals

Is Quest Diagnostics' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Quest Diagnostics. If investors know Quest will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Quest Diagnostics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Quarterly Earnings Growth

(0.03)

Dividend Share

2.88

Earnings Share

7.42

Revenue Per Share

83.105

Quarterly Revenue Growth

0.015

The market value of Quest Diagnostics is measured differently than its book value, which is the value of Quest that is recorded on the company's balance sheet. Investors also form their own opinion of Quest Diagnostics' value that differs from its market value or its book value, called intrinsic value, which is Quest Diagnostics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Quest Diagnostics' market value can be influenced by many factors that don't directly affect Quest Diagnostics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Quest Diagnostics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Quest Diagnostics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Quest Diagnostics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Quest Total Other Income Expense Net vs Selling And Marketing Expenses Analysis

Total Other Income Expense Net vs Selling And Marketing Expenses

Total Other Income Expense Net vs Selling And Marketing Expenses Correlation Analysis

Correlation Coefficient

Total Other Income Expense Net

Selling And Marketing Expenses

Quest Diagnostics fundamental ratios Correlations

Quest Diagnostics Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Quest Diagnostics fundamental ratios Accounts

Pair Trading with Quest Diagnostics

Moving against Quest Stock

Complementary Tools for Quest Stock analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Cash And Short Term Investments	+ 1.0	Cash
Total Stockholder Equity	+ 0.99	Total Assets
Non Current Assets Total	+ 0.99	Total Assets
Non Current Liabilities Total	+ 0.99	Total Assets
Total Liab	+ 0.99	Total Assets
Total Liab	+ 0.99	Short Long Term Debt Total

Other Stockholder Equity	- 0.95	Retained Earnings
Intangible Assets	- 0.81	Other Stockholder Equity
Other Stockholder Equity	- 0.81	Non Current Assets Total
Other Stockholder Equity	- 0.8	Total Stockholder Equity
Other Stockholder Equity	- 0.79	Total Assets
Total Liab	- 0.77	Other Stockholder Equity